-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Paratek Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- Paratek Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$9.41M, a 28.5% increase year-over-year.
- Paratek Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$44.5M, a 34.4% increase year-over-year.
- Paratek Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$46.2M, a 12.3% decline from 2021.
- Paratek Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$41.1M, a 45.5% increase from 2020.
- Paratek Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$75.5M, a 34.7% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)